EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT

Jianing Tang, Guo Long, Kuan Hu, Desheng Xiao, Shuang Liu, Liang Xiao, Ledu Zhou, Yongguang Tao iD

Advanced Science · 2023-11 · 10 (33)

DOI: 10.1002/advs.202302953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.10.2023. Verfasst von Jianing Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Hunan Provincial Key Area R&D Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a lethal and aggressive human malignancy. The present study examins the anti‐tumor effects of deubiquitylating enzymes (DUB) inhibitors in HCC. It is found that the inhibitor of ubiquitin specific peptidase 8 (USP8) and DUB‐IN‐3 shows the most effective anti‐cancer responses. Targeting USP8 inhibits the proliferation of HCC and induces cell ferroptosis. In vivo xenograft and metastasis experiments indicate that inhibition of USP8 suppresses tumor growth and lung metastasis. DUB‐IN‐3 treatment or USP8 depletion decrease intracellular cystine levels and glutathione biosynthesis while increasing the accumulation of reactive oxygen species (ROS). Mechanistical studies reveal that USP8 stabilizes O‐GlcNAc transferase (OGT) via inhibiting K48‐specific poly‐ubiquitination process on OGT protein at K117 site, and STE20‐like kinase (SLK)‐mediated S716 phosphorylation of USP8 is required for the interaction with OGT. Most importantly, OGT O‐GlcNAcylates solute carrier family 7, member 11 (SLC7A11) at Ser26 in HCC cells, which is essential for SLC7A11 to import the cystine from the extracellular environment. Collectively, this study demonstrates that pharmacological inhibition or knockout of USP8 can inhibit the progression of HCC and induce ferroptosis via decreasing the stability of OGT, which imposes a great challenge that targeting of USP8 is a potential approach for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsFerroptosisHumansCystineEndopeptidasesUbiquitin ThiolesteraseEndosomal Sorting Complexes Required for TransportAmino Acid Transport System y+N-Acetylglucosaminyltransferases

Stichwörter der Autor:innen

O-GlcNAcylationOGTUSP8deubiquitylationferroptosis

Substanzen

CystineEndopeptidasesUbiquitin ThiolesteraseEndosomal Sorting Complexes Required for TransportAmino Acid Transport System y+O-GlcNAc transferaseN-AcetylglucosaminyltransferasesUSP8 protein, humanSLC7A11 protein, human

Autor:innen und Institutionen

  • Department of Liver Surgery, Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Department of Oncology, Institute of Medical Sciences, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China.
  • Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Xiangya Hospital, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, China.
  • NHC Key Laboratory of Carcinogenesis (Central South University), Cancer Research Institute and School of Basic Medicine, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, China.

ORCID-Profile: Yongguang Tao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Hunan Provincial Key Area R&D Programs
  • Science and Technology Innovation Program of Hunan Province
  • Central South University Research Programme of Advanced Interdisciplinary Studies
  • Postdoctoral Research Foundation of China

Zitieren

APA

Tang, J., Long, G., Hu, K., Xiao, D., Liu, S., Xiao, L., Zhou, L., & Tao, Y. (2023). Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Advanced Science, 10(33). https://doi.org/10.1002/advs.202302953

Vancouver

Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Advanced Science. 2023;10(33). doi:10.1002/advs.202302953

BibTeX
@article{Tang2023,
  author = {Tang, Jianing and Long, Guo and Hu, Kuan and Xiao, Desheng and Liu, Shuang and Xiao, Liang and Zhou, Ledu and Tao, Yongguang},
  title = {Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {33},
  doi = {10.1002/advs.202302953}
}
Kostenlos starten →